ATXN1 and hepatocellular carcinoma: Mechanistically, miR-125b-5p promoted the EMT process and conferred stemness characteristics in PLC/PRF5-R1/R2 cells by targeting ATXN1, leading to the reduction of sorafenib sensitivity in HCC.